TABLE 1.
PHQ‐9 and GAD‐7 scores for all participants in the intervention arm, and a breakdown of the scores for the ineligible and eligible subgroups
Baseline | End‐of‐treatment | 3 months | 6 months | 9 months | |
---|---|---|---|---|---|
Intervention‐arm, n | 241 | 186 | 182 | 177 | 173 |
PHQ‐9 mean (SD) | 14.4 (4.9) | 8.2 (5.7) | 7.2 (5.8) | 6.8 (5.7) | 6.8 (5.5) |
GAD‐7 mean (SD) | 12.7 (4.7) | 7.4 (4.7) | 6.9 (5.3) | 6.5 (5.5) | 6.1 (4.8) |
Ineligible, n | 152 | 97 | 96 | 93 | 93 |
PHQ‐9 mean (SD) | 15.2 (5.0) | 11.9 (5.1) | 9.2 (6.1) | 8.9 (5.6) | 8.8 (5.7) |
GAD‐7 mean (SD) | 13.3 (4.7) | 11.2 (4.4) | 9.1 (5.9) | 8.5 (5.0) | 7.4 (4.9) |
Eligible, n | 89 | 89 | 86 | 84 | 80 |
PHQ9 mean (SD) | 13.0(4.5) | 4.0 (2.6) | 4.9 (4.6) | 4.6 (4.9) | 4.5 (4.3) |
GAD7 mean (SD) | 11.5 (4.5) | 3.2 (2.2) | 4.5 (3.9) | 4.2 (4.3) | 4.5 (4.3) |